1093.HK vs 640: Side-by-Side Comparison
Compare CSPC Pharmaceutical Group Limited (1093.HK) and China Resources Pharmaceutical Group Limited (640) side by side: market cap HKD 79.50B vs EUR 2.97B, P/E 17.9 vs 5.9. Financials, growth and model signals on Bullrun.
| Metric | 1093.HK | 640 |
|---|---|---|
| Company | CSPC Pharmaceutical Group Limited | China Resources Pharmaceutical Group Limited |
| Country / Exchange | Hong Kong | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - Specialty & Generic |
| Market cap | HKD 79.50B | EUR 2.97B |
| P/E ratio | 17.9 | 5.9 |
| Dividend yield | 4.20% | 5.14% |
| Valuation model | — | — |
| Revenue (FY2025) | HKD 26.01B | EUR 269.57B |
| Revenue growth YoY | -10.4% | +4.6% |
| Net income | HKD 3.88B | EUR 4.05B |
| Gross margin | 65.6% | 16.5% |
| Diluted EPS | 0.34 | 0.64 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.